GENOSCIENCE PHARMA has a total of 40 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are CARNA BIOSCIENCES INC, SHANTON PHARMA CO LTD and JONES PHILIP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | Brazil | 2 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Singapore | 2 | |
#10 | Chile | 1 | |
#11 | Costa Rica | 1 | |
#12 | Dominican Republic | 1 | |
#13 | EAPO (Eurasian Patent Organization) | 1 | |
#14 | Ecuador | 1 | |
#15 | EPO (European Patent Office) | 1 | |
#16 | Israel | 1 | |
#17 | Nicaragua | 1 | |
#18 | New Zealand | 1 | |
#19 | Peru | 1 | |
#20 | Philippines | 1 | |
#21 | Tunisia | 1 | |
#22 | Ukraine | 1 | |
#23 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Halfon Philippe | 34 |
#2 | Bassissi Firas | 30 |
#3 | Brun Sonia | 30 |
#4 | Beret Antoine | 27 |
#5 | Nicolas Gregory | 22 |
#6 | Courcambeck Jerome | 20 |
#7 | Dubray Clarisse | 12 |
#8 | Petit Serge | 11 |
#9 | Courcambeck Jérôme | 10 |
#10 | Nallet Jean Pierre | 10 |
Publication | Filing date | Title |
---|---|---|
CA3109887A1 | Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) related diseases | |
US2019144437A1 | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases | |
US2019314359A1 | Substituted 2,4 diamino-quinoline as new anticancer agents | |
WO2014147611A1 | Quinolines derivatives as novel anticancer agents | |
WO2012156825A1 | Peptide-based hiv pre-integration complex inhibitors | |
WO2010081851A1 | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |